Overview of key molecular and pharmacological targets for diabetes and associated diseases
Shahcheraghi, SH
Aljabali, AAA
Al Zoubi, MS
Mishra, V
Charbe, NB
Haggag, YA
Shrivastava, G
Almutary, AG
Alnuqaydan, AM
Barh, D
Dua, K
Chellappan, DK
Gupta, G
Lotfi, M
Serrano-Aroca, Á
Bahar, B
Mishra, YK
Takayama, K
Panda, PK
Bakshi, HA
Tambuwala, MM
- Publisher:
- Elsevier BV
- Publication Type:
- Journal Article
- Citation:
- Life Sciences, 2021, 278, pp. 119632-119632
- Issue Date:
- 2021-08
Closed Access
Filename | Description | Size | |||
---|---|---|---|---|---|
DIabetes_1-s2.0-S0024320521006184-main.pdf | Published version | 4.09 MB |
Copyright Clearance Process
- Recently Added
- In Progress
- Closed Access
This item is closed access and not available.
Full metadata record
Field | Value | Language |
---|---|---|
dc.contributor.author | Shahcheraghi, SH | |
dc.contributor.author | Aljabali, AAA | |
dc.contributor.author | Al Zoubi, MS | |
dc.contributor.author | Mishra, V | |
dc.contributor.author | Charbe, NB | |
dc.contributor.author | Haggag, YA | |
dc.contributor.author | Shrivastava, G | |
dc.contributor.author | Almutary, AG | |
dc.contributor.author | Alnuqaydan, AM | |
dc.contributor.author | Barh, D | |
dc.contributor.author |
Dua, K |
|
dc.contributor.author | Chellappan, DK | |
dc.contributor.author | Gupta, G | |
dc.contributor.author | Lotfi, M | |
dc.contributor.author | Serrano-Aroca, Á | |
dc.contributor.author | Bahar, B | |
dc.contributor.author | Mishra, YK | |
dc.contributor.author | Takayama, K | |
dc.contributor.author | Panda, PK | |
dc.contributor.author | Bakshi, HA | |
dc.contributor.author | Tambuwala, MM | |
dc.date.accessioned | 2021-05-23T12:06:08Z | |
dc.date.available | 2021-05-23T12:06:08Z | |
dc.date.issued | 2021-08 | |
dc.identifier.citation | Life Sciences, 2021, 278, pp. 119632-119632 | |
dc.identifier.issn | 0024-3205 | |
dc.identifier.uri | http://hdl.handle.net/10453/149080 | |
dc.language | en | |
dc.publisher | Elsevier BV | |
dc.relation.ispartof | Life Sciences | |
dc.relation.isbasedon | 10.1016/j.lfs.2021.119632 | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | 0601 Biochemistry and Cell Biology, 1115 Pharmacology and Pharmaceutical Sciences | |
dc.subject.classification | Pharmacology & Pharmacy | |
dc.title | Overview of key molecular and pharmacological targets for diabetes and associated diseases | |
dc.type | Journal Article | |
utslib.citation.volume | 278 | |
utslib.for | 0601 Biochemistry and Cell Biology | |
utslib.for | 1115 Pharmacology and Pharmaceutical Sciences | |
pubs.organisational-group | /University of Technology Sydney | |
pubs.organisational-group | /University of Technology Sydney/Faculty of Health | |
pubs.organisational-group | /University of Technology Sydney/Faculty of Health/Graduate School of Health | |
pubs.organisational-group | /University of Technology Sydney/Faculty of Health/Graduate School of Health/GSH.Pharmacy | |
utslib.copyright.status | closed_access | * |
dc.date.updated | 2021-05-23T12:06:05Z | |
pubs.publication-status | Accepted | |
pubs.volume | 278 |
Please use this identifier to cite or link to this item:
Download statistics for the last 12 months
Not enough data to produce graph